9 completed, 1 recruiting, 1 terminated. 11 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 9, Recruiting 1, Terminated 1 |
| Phase 2 | 4 | Completed 4 |
Follow Bronchoscopy: new trials by email Literature Review of Bronchoscopy trials Research Report on Bronchoscopy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation Meropenem, bronchoscopy, ventilator - ARDS, Septic Shock | Phase 1 / Phase 2 | Completed | King Abdul Aziz Specialist Hospital | 200 | 2020-07-02 | 2023-10-10 |
| Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation Meropenem, bronchoscopy, ventilator - ARDS, Septic Shock | Phase 1 / Phase 2 | Completed | King Abdul Aziz Specialist Hospital | 200 | 2020-07-02 | 2022-07-06 |
| Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation Meropenem, bronchoscopy, ventilator - ARDS, Septic Shock | Phase 1 / Phase 2 | Completed | King Abdul Aziz Specialist Hospital | 200 | 2020-07-02 | 2023-10-10 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2017-07-03 | 2026-11-12 |
| A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers RO7033877 + Bronchoscopy - Healthy Volunteer | Phase 1 | Completed | Hoffmann-La Roche | 32 | 2014-06-01 | 2016-11-02 |
| Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage, Phlebotomy - Asthma, Allergies | Phase 1 | Completed | Andrew D. Luster, M.D.,Ph.D. | 43 | 2013-01-01 | 2026-09-28 |
| T Cell Effector and Regulatory Mechanisms in Asthma Bronchoscopy, Segmental Allergen Challenge and Broncheoalveolar Lavage, PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging) - Asthma, Allergies | Phase 1 | Completed | Andrew D. Luster, M.D.,Ph.D. | 168 | 2012-09-01 | 2017-09-15 |
| Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage - Asthma | Phase 1 | Recruiting | Benjamin Medoff | 313 | 2008-01-01 | 2026-11-06 |
| Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol budesonide/formoterol fumarate dihydrate inhalation aerosol, DNA methylation analysis, comparative genomic hybridization - Lung Cancer, Precancerous Condition | Phase 1 | Completed | British Columbia Cancer Agency | 30 | 2007-01-01 | 2012-03-09 |
| Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma Prednisolone, Bronchoscopy - Asthma | Phase 1 | Terminated | GlaxoSmithKline | 47 | 2005-08-02 | 2017-08-04 |
| Carbon Monoxide to Prevent Lung Inflammation Bronchoscopy, Bronchoalveolar lavage, Endotoxin - Respiratory Distress Syndrome, Adult | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 35 | 2004-10-13 | 2019-12-17 |
Asthma (4) · Inflammation (3) · Shock, Septic (3) · Hypersensitivity (2) · Carcinoma, Non-Small-Cell Lung (1) · Constriction, Pathologic (1) · Lung Neoplasms (1) · Lymphoma, AIDS-Related (1) · Lymphoma, B-Cell (1) · Lymphoma, Primary Effusion (1) · Precancerous Conditions (1) · Respiratory Distress Syndrome (1)
King Abdul Aziz Specialist Hospital (3) · Andrew D. Luster, M.D.,Ph.D. (2) · Benjamin Medoff (1) · British Columbia Cancer Agency (1) · GlaxoSmithKline (1) · Hoffmann-La Roche (1) · National Cancer Institute (NCI) (1) · National Institutes of Health Clinical Center (CC) (1)
United States (6) · Saudi Arabia (3) · Canada (1) · United Kingdom (1)
Andrew D Luster, M.D., Ph.D. (2) · Anthony F Suffredini, M.D. (1) · Benjamin D Medoff, MD, PhD (1) · Ramya Ramaswami, MBBS, MPH (1) · Stephen Lam, MD (1)
PMID 24386300, PMID 29550052, PMID 35868533
U19AI095261 (2)